Literature DB >> 6177091

Diagnosis of human childhood rhabdomyosarcoma of antibodies to desmin, the structural protein of muscle specific intermediate filaments.

M Altmannsberger, M Osborn, J Treuner, A Hölscher, K Weber, A Shauer.   

Abstract

Four embryonal rhabdomyosarcomas, one tumor diagnosed as an undifferentiated sarcoma, probably a rhabdomyosarcoma, and six different non-muscular sarcomas were investigated with antibodies specific for different intermediate filament types. The tumor cells in the rhabdomyosarcomas and the undifferentiated tumor were stained clearly by antibodies to desmin, the intermediate filament type characteristic of muscle. The staining of tumor cell by antibodies to vimentin, the intermediate filament type characteristic of certain cell types of mesenchymal origin including myoblasts, was different in these 5 cases. In one case of embryonal rhabdomyosarcoma nearly all tumor cells were stained, but in the remaining cases few or no tumor cells were positive with the vimentin antibody. In these rhabdomyosarcomas not only the large rhabdomyoblasts, but also the small undifferentiated cells were labeled by antibodies to desmin. In the latter cell type the desmin filaments were arranged typically in coils. In contrast, tumor cells in the non-muscular mesenchymal sarcomas were stained only by antibodies to vimentin but not by antibodies to desmin or prekeratin. The retention of the desmin marker characteristic of normal muscle in cases of rhabdomyosarcoma not only allowed the undifferentiated desmin-positive sarcoma to be classified as rhabdomyosarcoma but also suggests that the use of antibodies to desmin could be very helpful in the future for the diagnosis of undifferentiated rhabdomyosarcomas.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177091     DOI: 10.1007/BF02892848

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  23 in total

1.  Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.

Authors:  R A Schmidt; R Cone; J E Haas; A M Gown
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

2.  Antibody specific to muscle actins in the diagnosis and classification of soft tissue tumors.

Authors:  M Miettinen
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  Diagnostic value of intermediate filament antibodies in clinical cytology.

Authors:  M Altmannsberger; M Osborn; M Droese; K Weber; A Schauer
Journal:  Klin Wochenschr       Date:  1984-02-01

4.  Myofibrillogenesis in primary tissue cultures of adult human skeletal muscle: expression of desmin, titin, and nebulin.

Authors:  T Behr; P Fischer; W Müller-Felber; M Schmidt-Achert; D Pongratz
Journal:  Clin Investig       Date:  1994-01

5.  All histological types of primary human rhabdomyosarcoma express alpha-cardiac and not alpha-skeletal actin messenger RNA.

Authors:  W Schürch; M L Bochaton-Piallat; A Geinoz; E d'Amore; R N Laurini; M Cintorino; L R Bégin; Y Boivin; G Gabbiani
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

6.  Antibodies to cytokeratin and vimentin in testicular tumour diagnosis.

Authors:  F Ramaekers; W Feitz; O Moesker; G Schaart; C Herman; F Debruyne; P Vooijs
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

7.  Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas.

Authors:  O Skalli; G Gabbiani; F Babaï; T A Seemayer; G Pizzolato; W Schürch
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

8.  Malignant melanomas contain only the vimentin type of intermediate filaments.

Authors:  J Caselitz; M Jänner; E Breitbart; K Weber; M Osborn
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

9.  Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies.

Authors:  M Miettinen; V P Lehto; D Dahl; I Virtanen
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

10.  Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies.

Authors:  E Debus; R Moll; W W Franke; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.